Showing results (2491-2500 of 9,335) with videos related to
Sort By:
Pageof 934
Cancer Medicine|February 1, 2022
BMI changes and the risk of lung cancer in male never-smokers: A prospective cohort studyZheng Wu, Shuanghua Xie, Fei Wang, et al.Cancer Medicine|June 21, 2019
The immunostimulatory effects and pro-apoptotic activity of rhCNB against Lewis lung cancer is mediated by Toll-like receptor 4Jinju Yang, Hongwei Zhang, Ziwei Zhu, et al.Cancer Medicine|June 22, 2019
Genomic analysis of pancreatic juice DNA assesses malignant risk of intraductal papillary mucinous neoplasm of pancreasRaúl N Mateos, Hidewaki Nakagawa, Seiko Hirono, et al.Cancer Medicine|June 20, 2019
Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort studyHeather S Feigelson, John D Powers, Mayanka Kumar, et al.Cancer Medicine|October 25, 2021
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancerTorben Steiniche, Sun Young Rha, Hyun Cheol Chung, et al.Cancer Medicine|June 28, 2019
Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive womenXiaojun Chen, Sun Wei, Hongxia Ma, et al.Cancer Medicine|June 28, 2019
Prognostic impact of intraoperative peritoneal cytology in interval debulking surgery for pelvic high-grade serous carcinomaNaoki Kojima, Hiroshi Yoshida, Ikumi Kuno, et al.Cancer Medicine|June 28, 2019
Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancerWen Ouyang, Jing Yu, Shuake Nuerjiang, et al.Cancer Medicine|July 3, 2019
Distribution of hospital care among pediatric and young adult Hodgkin lymphoma survivors-A population-based cohort study from Sweden and DenmarkIngrid Glimelius, Annika Englund, Klaus Rostgaard, et al.Cancer Medicine|February 22, 2022
The real-world clinical outcomes and treatment patterns of patients with unresectable locally advanced or metastatic soft tissue sarcoma treated with anlotinib in the post-ALTER0203 trial eraRen-Shu Zhang, Jie Liu, Yao-Tiao Deng, et al.Pageof 934